European regulators have given Cerus Endovascular CE mark approval for its Contour neurovascular system, a device intended for the treatment of intracranial aneurysms. The system, which provides flow disruption and flow diversion because its fine mesh braid is deployed at an aneurysm neck, will be released on a controlled basis in select EU markets in the third quarter.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.